Efecto del almacenamiento en frío, el tiempo y la población de especies de Pseudomonas sobre la lipolisis de la leche

The aim of this study was to evaluate the lipolytic index (LI) of Pseudomonas fluorescens and Pseudomonas putida (2, 5, 6 log CFU/mL) in milk during 96 h by the Lipo R method. The strains were isolated from refrigerated raw milk (30 °C, 48 h), and species were confirmed by PCR, inoculated in reconstituted whole milk, and stored at 2 °C, 4 °C, and 8 °C. The storage time (ST) and temperature were associated with LI of P. putida. The interaction among lipolysis, temperature, and ST occurs even with a low population of P. putida and these variables combined together contributed to about 77% of the free fatty acids (FFA) in milk. The ST, temperature, and population of P. fluorescens showed a significant effect on its LI, and the variables contributed to about 43% of FFA. LI was about 224% higher in milk with P. fluorescens than with P. putida. The reduc-tion in ST and milk temperature resulted in a decrease in lipid lysis and a lower index of FFA by P. putida and P. fluorescens, with P. fluorescens showing a higher lipolytic capacity.El objetivo fue evaluar el índice lipolítico (LI) (por el método Lipo R) de Pseudomonas fluorescens y Pseudomonas putidas (2, 5, 6 log CFU / mL) en leche durante 96 h. Las cepas se aislaron de leche cruda refrigerada (30 °C, 48 h), las especies se confirmaron por PCR, se inocularon en leche entera reconsti-tuida y se almacenaron a 2, 4 y 8 °C. El tiempo de almacenamiento (ST) y la temperatura se asociaron con LI de P. putida. La interacción entre lipólisis, temperatura y ST ocurre incluso con una población baja de P. putida y estas variables combinadas contribuyeron a aproximadamente el 77% de los ácidos grasos libres (FFA) en la leche. El ST, la temperatura y la población de P. fluorescens mostraron un efecto significativo en su LI, y las variables contribuyeron a aproximadamente el 43% de FFA. LI fue aproximadamente un 224% mayor en leche con P. fluorescens que con P. putida. La reducción de la temperatura de ST y de la leche dio como resultado una disminución en la lisis lipídica y un índice más bajo de FFA por P. putida y P. fluorescens, esta última mostrando una mayor capacidad lipolítica

A second new species for the rare dipsadid genus Caaeteboia Zaher et al., 2009 (Serpentes: Dipsadidae) from the Atlantic Forest of northeastern Brazil

Caaeteboia is a rare and elusive monotypic genus of Neotropical snake, being one of the least known dipsadids of the Brazilian Atlantic Forest. Here, we assess the morphological and genetic diversity of this genus, comparing these results with several other genera of Xenodontinae. Our combined results revealed the presence of an unknown species from the northeastern portion of the Atlantic Forest. The new species is distributed throughout the enclaves of coastal open forests mixed with savanna-like habitat, locally known as “Floresta de Tabuleiro”, and submontane ombrophilous forests in the Brazilian states of Paraíba and Pernambuco. This new species is easily distinguished from C. amarali by its lower number of dorsal, ventral, and subcaudal scales, and a remarkable dark lateral stripe from the nostril up to the anterior third of the body. The new species extends the distribution of the genus in approximately 700 kilometers northwards, reinforcing the importance of the conservation of small remnants of Atlantic Forest in northeastern Brazil, which still harbor high levels of endemicity and diversity.Caaeteboia é um gênero de serpente raro e monotípico da região Neotropical, sendo um dos dipsadídeos menos conhecidos da Floresta Atlântica brasileira. Neste trabalho, avaliamos a diversidade morfológica e genética desse gênero, comparando-o com outros gêneros de Xenodontinae. Nossos resultados combinados revelaram a presença de uma espécie desconhecida da porção nordeste da Floresta Atlântica. A nova espécie se distribui ao longo dos enclaves de florestas abertas costeiras misturadas com habitats savânicos, conhecidos localmente por “Florestas de Tabuleiro”, e florestas ombrófilas submontanas nos estados da Paraíba e de Pernambuco. Essa nova espécie é distinguida de C. amarali pelo menor número de escamas dorsais, ventrais e subcaudais, e por uma evidente linha escura lateral desde o focinho até o terço anterior do corpo. A nova espécie amplia a distribuição do gênero para aproximadamente 700 quilômetros ao norte, e reforça a importância da conservação dos pequenos remanescentes de Floresta Atlântica no nordeste do Brasil, os quais ainda abrigam altos níveis de endemismo e diversidade.Asociación Herpetológica Argentin

A second new species for the rare dipsadid genus Caaeteboia Zaher et al., 2009 (Serpentes: Dipsadidae) from the Atlantic Forest of northeastern Brazil

Caaeteboia is a rare and elusive monotypic genus of Neotropical snake, being one of the least known dipsadids of the Brazilian Atlantic Forest. Here, we assess the morphological and genetic diversity of this genus, comparing these results with several other genera of Xenodontinae. Our combined results revealed the presence of an unknown species from the northeastern portion of the Atlantic Forest. The new species is distributed throughout the enclaves of coastal open forests mixed with savanna-like habitat, locally known as “Floresta de Tabuleiro”, and submontane ombrophilous forests in the Brazilian states of Paraíba and Pernambuco. This new species is easily distinguished from C. amarali by its lower number of dorsal, ventral, and subcaudal scales, and a remarkable dark lateral stripe from the nostril up to the anterior third of the body. The new species extends the distribution of the genus in approximately 700 kilometers northwards, reinforcing the importance of the conservation of small remnants of Atlantic Forest in northeastern Brazil, which still harbor high levels of endemicity and diversity.Caaeteboia é um gênero de serpente raro e monotípico da região Neotropical, sendo um dos dipsadídeos menos conhecidos da Floresta Atlântica brasileira. Neste trabalho, avaliamos a diversidade morfológica e genética desse gênero, comparando-o com outros gêneros de Xenodontinae. Nossos resultados combinados revelaram a presença de uma espécie desconhecida da porção nordeste da Floresta Atlântica. A nova espécie se distribui ao longo dos enclaves de florestas abertas costeiras misturadas com habitats savânicos, conhecidos localmente por “Florestas de Tabuleiro”, e florestas ombrófilas submontanas nos estados da Paraíba e de Pernambuco. Essa nova espécie é distinguida de C. amarali pelo menor número de escamas dorsais, ventrais e subcaudais, e por uma evidente linha escura lateral desde o focinho até o terço anterior do corpo. A nova espécie amplia a distribuição do gênero para aproximadamente 700 quilômetros ao norte, e reforça a importância da conservação dos pequenos remanescentes de Floresta Atlântica no nordeste do Brasil, os quais ainda abrigam altos níveis de endemismo e diversidade.Asociación Herpetológica Argentin

Multidisciplinary scientific cruise to the Rio Grande Rise

The full text of this article can be freely accessed on the publisher's website

Language impairment in the genetic forms of behavioural variant frontotemporal dementia

Background: Behavioural variant fronto-temporal dementia (bvFTD) is characterised by a progressive change in personality in association with atrophy of the frontal and temporal lobes. Whilst language impairment has been described in people with bvFTD, little is currently known about the extent or type of linguistic difficulties that occur, particularly in the genetic forms. Methods: Participants with genetic bvFTD along with healthy controls were recruited from the international multicentre Genetic FTD Initiative (GENFI). Linguistic symptoms were assessed using items from the Progressive Aphasia Severity Scale (PASS). Additionally, participants undertook the Boston Naming Test (BNT), modified Camel and Cactus Test (mCCT) and a category fluency test. Participants underwent a 3T volumetric T1-weighted MRI, with language network regional brain volumes measured and compared between the genetic groups and controls. Results: 76% of the genetic bvFTD cohort had impairment in at least one language symptom: 83% C9orf72, 80% MAPT and 56% GRN mutation carriers. All three genetic groups had significantly impaired functional communication, decreased fluency, and impaired sentence comprehension. C9orf72 mutation carriers also had significantly impaired articulation and word retrieval as well as dysgraphia whilst the MAPT mutation group also had impaired word retrieval and single word comprehension. All three groups had difficulties with naming, semantic knowledge and verbal fluency. Atrophy in key left perisylvian language regions differed between the groups, with generalised involvement in the C9orf72 group and more focal temporal and insula involvement in the other groups. Correlates of language symptoms and test scores also differed between the groups. Conclusions: Language deficits exist in a substantial proportion of people with familial bvFTD across all three genetic groups. Significant atrophy is seen in the dominant perisylvian language areas and correlates with language impairments within each of the genetic groups. Improved understanding of the language phenotype in the main genetic bvFTD subtypes will be helpful in future studies, particularly in clinical trials where accurate stratification and monitoring of disease progression is required.info:eu-repo/semantics/publishedVersio

CSF glial markers are elevated in a subset of patients with genetic frontotemporal dementia

Background: Neuroinflammation has been shown to be an important pathophysiological disease mechanism in frontotemporal dementia (FTD). This includes activation of microglia, a process that can be measured in life through assaying different glia-derived biomarkers in cerebrospinal fluid. However, only a few studies so far have taken place in FTD, and even fewer focusing on the genetic forms of FTD. Methods: We investigated the cerebrospinal fluid concentrations of TREM2, YKL-40 and chitotriosidase using immunoassays in 183 participants from the Genetic FTD Initiative (GENFI) study: 49 C9orf72 (36 presymptomatic, 13 symptomatic), 49 GRN (37 presymptomatic, 12 symptomatic) and 23 MAPT (16 presymptomatic, 7 symptomatic) mutation carriers and 62 mutation-negative controls. Concentrations were compared between groups using a linear regression model adjusting for age and sex, with 95% bias-corrected bootstrapped confidence intervals. Concentrations in each group were correlated with the Mini-Mental State Examination (MMSE) score using non-parametric partial correlations adjusting for age. Age-adjusted z-scores were also created for the concentration of markers in each participant, investigating how many had a value above the 95th percentile of controls. Results: Only chitotriosidase in symptomatic GRN mutation carriers had a concentration significantly higher than controls. No group had higher TREM2 or YKL-40 concentrations than controls after adjusting for age and sex. There was a significant negative correlation of chitotriosidase concentration with MMSE in presymptomatic GRN mutation carriers. In the symptomatic groups, for TREM2 31% of C9orf72, 25% of GRN, and 14% of MAPT mutation carriers had a concentration above the 95th percentile of controls. For YKL-40 this was 8% C9orf72, 8% GRN and 0% MAPT mutation carriers, whilst for chitotriosidase it was 23% C9orf72, 50% GRN, and 29% MAPT mutation carriers. Conclusions: Although chitotriosidase concentrations in GRN mutation carriers were the only significantly raised glia-derived biomarker as a group, a subset of mutation carriers in all three groups, particularly for chitotriosidase and TREM2, had elevated concentrations. Further work is required to understand the variability in concentrations and the extent of neuroinflammation across the genetic forms of FTD. However, the current findings suggest limited utility of these measures in forthcoming trials.info:eu-repo/semantics/publishedVersio

Structural MRI predicts clinical progression in presymptomatic genetic frontotemporal dementia: findings from the GENetic Frontotemporal dementia Initiative (GENFI) cohort

Abstract Biomarkers that can predict disease progression in individuals with genetic frontotemporal dementia are urgently needed. We aimed to identify whether baseline MRI-based grey and white matter abnormalities are associated with different clinical progression profiles in presymptomatic mutation carriers in the GENetic Frontotemporal dementia Initiative. 387 mutation carriers were included (160 GRN, 160 C9orf72, 67 MAPT), together with 240 non-carrier cognitively normal controls. Cortical and subcortical grey matter volumes were generated using automated parcellation methods on volumetric 3 T T1-weighted MRI scans, while white matter characteristics were estimated using diffusion tensor imaging. Mutation carriers were divided into two disease stages based on their global CDR®+NACC-FTLD score: presymptomatic (0 or 0.5) and fully symptomatic (1 or greater). W-scores in each grey matter volumes and white matter diffusion measures were computed to quantify the degree of abnormality compared to controls for each presymptomatic carrier, adjusting for their age, sex, total intracranial volume, and scanner type. Presymptomatic carriers were classified as “normal” or “abnormal” based on whether their grey matter volume and white matter diffusion measure w-scores were above or below the cut point corresponding to the 10th percentile of the controls. We then compared the change in disease severity between baseline and one year later in both the “normal” and “abnormal” groups within each genetic subtype, as measured by the CDR®+NACC-FTLD sum-of-boxes score and revised Cambridge Behavioural Inventory total score. Overall, presymptomatic carriers with normal regional w-scores at baseline did not progress clinically as much as those with abnormal regional w-scores. Having abnormal grey or white matter measures at baseline was associated with a statistically significant increase in the CDR®+NACC-FTLD of up to 4 points in C9orf72 expansion carriers, and 5 points in the GRN group as well as a statistically significant increase in the revised Cambridge Behavioural Inventory of up to 11 points in MAPT, 10 points in GRN, and 8 points in C9orf72 mutation carriers. Baseline regional brain abnormalities on MRI in presymptomatic mutation carriers are associated with different profiles of clinical progression over time. These results may be helpful to inform stratification of participants in future trials